Table 1 Bacterial distribution in the control group (CG) and treatment group (TG) at T1 (dry-off), T2 (colostrum), and T3 (5–10 DIM). Average number of positive samples per timepoint and treatment and corresponding percentages (between brackets).

From: Use of approved cefazolin based intramammary dry goat treatment and its effects on the milk microbiota

Bacteria

Experimental group

T1

T2

T3

Staphylococcus caprae

CG

8 (29%)

7 (29%)

6 (21%)

 

TG

1 (4%)

2 (9%)

1 (4%)

Staphylococcus equorum

CG

4 (14%)

8 (33%)

-

 

TG

4 (15%)

5 (22%)

-

Staphylococcus aureus

CG

-

-

-

 

TG

3 (11%)

-

1 (4%)

Serratia marcescens

CG

2 (7%)

-

3 (11%)

 

TG

3 (11%)

3 (13%)

2 (7%)

Other NAS

CG

-

2 (8%)

1 (4%)

 

TG

-

7 (30%)

-

Others*

CG

-

1 (4%)

1 (4%)

 

TG

1 (4%)

1 (4%)

-

No growth

CG

14 (50%)

5 (21%)

15 (54%)

 

TG

15 (56%)

5 (22%)

23 (85%)

Contamination

CG

-

1 (4%)

2 (7%)

 

TG

-

-

-

Total

CG

28 (100%)

24 (100%)

28 (100%)

 

TG

27 (100%)

23 (100%)

27 (100%)

  1. *Other NASs include Staphylococcus warneri and Staphylococcus succinus.
  2. **Others include Escherichia coli, Corynebacterium stationis, and Lactococcus lactis.